Inventor
CALLAHAN JAMES F
US31 patents
⚠️ This page may combine multiple inventors who share the name “CALLAHAN JAMES F”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SMITHKLINE BEECHAM CORP
11 patentsUS7166639B2Jan 23, 2007
NF-κB inhibitors
SMITHKLINE BEECHAM CORP38 citations91
US6465493B1Oct 15, 2002
Triarylimidazoles
SMITHKLINE BEECHAM CORP49 citations91
US6492425B1Dec 10, 2002
Inhibitors of transcription factor-NF-κB
SMITHKLINE BEECHAM CORP42 citations88
US6864267B2Mar 8, 2005
Calcilytic compounds
SMITHKLINE BEECHAM CORP21 citations86
US5470849ANov 28, 1995
γ-turn peptidomimetics as fibrinogen antagonists
SMITHKLINE BEECHAM CORP17 citations74
US7087758B2Aug 8, 2006
Quinoline inhibitors of hyaki and hyak3 kinases
SMITHKLINE BEECHAM CORP10 citations71
US7300952B2Nov 27, 2007
NF-κb inhibitors
SMITHKLINE BEECHAM CORP0 citations52
US7629350B2Dec 8, 2009
Compounds
SMITHKLINE BEECHAM CORP0 citations42
US7183311B2Feb 27, 2007
NF-κB inhibitors
SMITHKLINE BEECHAM CORP0 citations42
US5539104AJul 23, 1996
1,4 Diazocines as fibrinogen antagonists
SMITHKLINE BEECHAM CORP0 citations42
US7482455B2Jan 27, 2009
Chemical compounds
SMITHKLINE BEECHAM CORP0 citations38
SMITHKLINE BECKMAN CORP
8 patentsUS4604378AAug 5, 1986
Basic V1 -vasopressin antagonists
SMITHKLINE BECKMAN CORP19 citations81
US4908475AMar 13, 1990
Intermediates for preparing 1,6-dicarba-vasopressin compounds
SMITHKLINE BECKMAN CORP6 citations73
US4760052AJul 26, 1988
1,6-dicarba-vasopressin compounds
SMITHKLINE BECKMAN CORP8 citations73
US4543349ASep 24, 1985
Basic heptapeptide vasopressin antagonists
SMITHKLINE BECKMAN CORP11 citations73
US4810778AMar 7, 1989
Intermediates for preparing 1,6-dicarba-vasopressin compounds
SMITHKLINE BECKMAN CORP2 citations62
US4684621AAug 4, 1987
Methods of producing vasodilation or antioxytocic activity
SMITHKLINE BECKMAN CORP5 citations62
US4658015AApr 14, 1987
Polypeptide intermediates
SMITHKLINE BECKMAN CORP1 citations51
US4624943ANov 25, 1986
Aromatic basic-tailed vasopressin antagonists
SMITHKLINE BECKMAN CORP1 citations51
NPS PHARMA INC
5 patentsUS6022894AFeb 8, 2000
Method of using calcilytic compounds
NPS PHARMA INC51 citations95
US6521667B1Feb 18, 2003
Calcilytic compounds
NPS PHARMA INC28 citations91
US6432656B1Aug 13, 2002
Calcilytic compounds
NPS PHARMA INC41 citations91
US7202261B2Apr 10, 2007
Calcilytic compounds
NPS PHARMA INC13 citations83
US6818660B2Nov 16, 2004
Calcilytic compounds
NPS PHARMA INC14 citations83
GLAXO GROUP LTD
4 patentsUS7479558B2Jan 20, 2009
Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivatives
GLAXO GROUP LTD5 citations62
US7678801B2Mar 16, 2010
Compounds
GLAXO GROUP LTD2 citations60
US7674789B2Mar 9, 2010
Compounds
GLAXO GROUP LTD1 citations51
US8354416B2Jan 15, 2013
7,8-dihydropyrido[2,3-d]pyrimidin-4-yl substituted compounds as inhibitors of p38 kinase
GLAXO GROUP LTD0 citations50